Fulcrum Therapeutics (FULC) Return on Sales (2020 - 2025)
Fulcrum Therapeutics (FULC) posted quarterly Return on Sales of 0.02% for Q2 2025, down 2.0% year-over-year from 0.02% in Q2 2024, and down 54.75% quarter-over-quarter from 0.01% in Q4 2024.
Fulcrum Therapeutics (FULC) Return on Sales (2020 - 2025) Analysis & Trends
Fulcrum Therapeutics (FULC) has reported Return on Sales for 6 consecutive years, with 0.02% the latest figure, recorded in Q2 2025.
- In Q2 2025, Return on Sales fell 2.0% year-over-year to 0.02%; the TTM figure through Jun 2025 stood at 0.02% (changed 0.0% YoY), while the FY2024 annual figure was 0.01%, up 97.0% from the prior year.
- Return on Sales declined to 0.02% in Q2 2025 per FULC's latest filing, from 0.01% in the prior quarter.
- Across five years, Return on Sales topped out at 0.01% in Q2 2024 and bottomed at 1.42% in Q1 2023.
- Historically, Return on Sales has averaged 0.34% across 5 years, with a median of 0.27% in 2022.
- Annual changes were most pronounced in 2023 — Return on Sales plunged 106 bps — and 2024, when it surged 66 bps.
- Fulcrum Therapeutics' Return on Sales stood at 0.23% in 2021, then sank by 86 bps to 0.44% in 2022, then retreated by 14 bps to 0.49% in 2023, then surged by 98 bps to 0.01% in 2024, then tumbled by 55 bps to 0.02% in 2025.
- Business Quant data shows FULC's Return on Sales at 0.02% in Q2 2025, 0.01% in Q4 2024, and 0.01% in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 0.00% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.00% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.00% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.00% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.00% |
| 10 | Fulcrum Therapeutics | 285.31 Mn | 285.31 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -0.02% |
| Dec 31, 2024 | -0.01% |
| Sep 30, 2024 | -0.01% |
| Jun 30, 2024 | 0.01% |
| Mar 31, 2024 | -0.71% |
| Dec 31, 2023 | -0.49% |
| Sep 30, 2023 | -0.53% |
| Jun 30, 2023 | -0.35% |
| Mar 31, 2023 | -1.03% |
| Dec 31, 2022 | -2.81% |
| Sep 30, 2022 | -0.23% |
| Jun 30, 2022 | -0.19% |
| Mar 31, 2022 | -0.36% |
| Dec 31, 2021 | -0.10% |
| Sep 30, 2021 | -0.20% |
| Jun 30, 2021 | -0.09% |
| Mar 31, 2021 | -0.05% |
| Dec 31, 2020 | -0.04% |
| Sep 30, 2020 | -0.21% |
| Jun 30, 2020 | -0.17% |